Apr. 18, 2026
Trump Signs Order to Expedite Psychedelics Testing for PTSD Treatment
Executive action follows text from podcaster Joe Rogan to the president
Apr. 18, 2026
Federal Action Advances Psychedelic Research and Policy
MAPS welcomes $50 million investment in studying compounds like ibogaine, psilocybin, and MDMA for mental health treatments
Apr. 18, 2026
Trump Directs Faster Review of Psychedelic Drugs for Medical Use
The administration aims to accelerate access to potential treatments like ibogaine for conditions like PTSD and addiction.